SAN RAFAEL, Calif. , June 15, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in the BofA Securities 2021 Napa Biopharma Conference on June 16, 2021 at 3:30pm ET . An audio webcast of the presentation will be available live. You can access the webcast at: https://investors.biomarin.com/ . An archived version of the remarks will also be available through the Company's website for a limited time following the conference.
About BioMarin
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.
For additional information, please visit www.biomarin.com . Information on BioMarin's website is not incorporated by reference into this press release.
|
Contacts:
|
|
|
|
|
Investors
|
Media
|
|
Traci McCarty
|
Debra Charlesworth
|
|
BioMarin Pharmaceutical Inc.
|
BioMarin Pharmaceutical Inc.
|
|
(415) 455-7558
|
(415) 455-7451
|
View original content to download multimedia: http://www.prnewswire.com/news-releases/biomarin-to-participate-in-the-virtual-bofa-securities-2021-napa-biopharma-conference-301312288.html
SOURCE BioMarin Pharmaceutical Inc.
